099190.KQ
i-SENS, Inc.
1W: -0.2%
1M: -23.3%
3M: +24.5%
YTD: +7.7%
1Y: +14.7%
3Y: +27.5%
5Y: +38.1%
₩20,050.00 ($13.33)
-650.00 (-3.14%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩571.0B ($379.6M)
52W Range12970-27600
Volume100,189
Avg Volume266,968
Beta0.72
Dividend₩100.00
Analyst Ratings
No analyst coverage
Company Info
CEOGeun-Sig Cha
Employees687
SectorHealthcare
IndustryMedical - Specialties
IPO Date2013-01-30
Websitei-sens.com
43, Banpo-daero 28-gil
Seoul 06646
KR
Seoul 06646
KR
82 70 7093 9609
About i-SENS, Inc.
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Recent Insider Trades
No insider trades found